DigitalHealth.London Accelerator company, Vital Signs Solutions (creators of the PocDoc platform), has announced with Innovate UK to to digital reader for Covid-19 lateral flow tests.
Vital Signs Solutions will be using image analysis algorithms and adapting its app-based, cloud-first reader technology platform, PocDoc to develop an application that can assist in the digital self-reporting of lateral flow test results.
The PocDoc platform allows anyone with a smartphone or tablet to test themselves for a range of major diseases, obtaining results and a full health assessment in minutes.
Vital Signs Solutions has developed a range of their own lateral flow tests, focusing first on Cardiovascular Disease, and has recently announced a partnership wtih PATH to scale Polio testing in the developing world.
Steve Roest, CEO of Vital Signs Solutions and PocDoc said “We are thrilled to be partnering with the Department of Health and Social Care and NHS Digital to continue the fight against Covid-19. The DigitalHealth.London Accelerator has helped us develop and deploy the PocDoc platform at scale to unlock the power of digitally enabled rapid testing in the healthcare system – whether for Covid-19, Cardiovascular Disease or Diabetes. The programme is rightly considered to be one of the best HealthTech Accelerators in the world and we are honoured to have been part of this year’s cohort.”
PocDoc has also been successfully accepted as a suitable employer under the UK Government’s Kickstart scheme and have started hiring young people who were otherwise out of work to help us grow PocDoc and make a difference in the fight against major diseases. The scheme connects fast-growing companies who are willing to mentor young people who’s job prospects were affected by the Covid-19 pandemic.
PocDoc is currently one of 20 digital health companies on the DigitalHealth.London Accelerator programme.
The DigitalHealth.London Accelerator is a collaborative programme funded by London’s three Academic Health Science Networks – UCL Partners, Imperial College Health Partners, and the Health Innovation Network, MedCity, CW+ and receives match funding from the European Regional Development Fund.